Logo image of RDIB

READING INTERNATIONAL INC-B (RDIB) Stock Fundamental Analysis

USA - NASDAQ:RDIB - US7554082005 - Common Stock

11.41 USD
-0.74 (-6.09%)
Last: 9/19/2025, 8:00:01 PM
Fundamental Rating

1

Overall RDIB gets a fundamental rating of 1 out of 10. We evaluated RDIB against 80 industry peers in the Entertainment industry. RDIB has a bad profitability rating. Also its financial health evaluation is rather negative. RDIB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDIB had negative earnings in the past year.
In the past year RDIB had a positive cash flow from operations.
RDIB had negative earnings in 4 of the past 5 years.
RDIB had a negative operating cash flow in each of the past 5 years.
RDIB Yearly Net Income VS EBIT VS OCF VS FCFRDIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.60%, RDIB is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -4.6%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDIB Yearly ROA, ROE, ROICRDIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

The Gross Margin of RDIB (12.85%) is worse than 80.00% of its industry peers.
RDIB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RDIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDIB Yearly Profit, Operating, Gross MarginsRDIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

RDIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
RDIB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RDIB has more shares outstanding
Compared to 1 year ago, RDIB has a worse debt to assets ratio.
RDIB Yearly Shares OutstandingRDIB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDIB Yearly Total Debt VS Total AssetsRDIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

RDIB has an Altman-Z score of 0.14. This is a bad value and indicates that RDIB is not financially healthy and even has some risk of bankruptcy.
RDIB has a Altman-Z score of 0.14. This is in the lower half of the industry: RDIB underperforms 61.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.14
ROIC/WACCN/A
WACC9.09%
RDIB Yearly LT Debt VS Equity VS FCFRDIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.16 indicates that RDIB may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.16, RDIB is doing worse than 90.00% of the companies in the same industry.
A Quick Ratio of 0.15 indicates that RDIB may have some problems paying its short term obligations.
With a Quick ratio value of 0.15, RDIB is not doing good in the industry: 88.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.15
RDIB Yearly Current Assets VS Current LiabilitesRDIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.08% over the past year.
RDIB shows a small growth in Revenue. In the last year, the Revenue has grown by 7.57%.
Measured over the past years, RDIB shows a decrease in Revenue. The Revenue has been decreasing by -5.33% on average per year.
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)7.57%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%

3.2 Future

RDIB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.82% yearly.
The Revenue is expected to grow by 7.38% on average over the next years.
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDIB Yearly Revenue VS EstimatesRDIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDIB Yearly EPS VS EstimatesRDIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDIB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDIB Price Earnings VS Forward Price EarningsRDIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

RDIB's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 53.5
RDIB Per share dataRDIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

RDIB's earnings are expected to grow with 28.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.75%
EPS Next 3Y28.82%

More info and screens

0

5. Dividend

5.1 Amount

RDIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

READING INTERNATIONAL INC-B

NASDAQ:RDIB (9/19/2025, 8:00:01 PM)

11.41

-0.74 (-6.09%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners46.89%
Inst Owner Change2.96%
Ins Owners6.33%
Ins Owner Change0%
Market Cap259.24M
Analysts80
Price Target19.69 (72.57%)
Short Float %0.03%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.69%
Min EPS beat(2)-112.16%
Max EPS beat(2)48.79%
EPS beat(4)2
Avg EPS beat(4)-35.24%
Min EPS beat(4)-114.64%
Max EPS beat(4)48.79%
EPS beat(8)2
Avg EPS beat(8)-381.47%
EPS beat(12)3
Avg EPS beat(12)-294.48%
EPS beat(16)4
Avg EPS beat(16)-225.8%
Revenue beat(2)0
Avg Revenue beat(2)-6.42%
Min Revenue beat(2)-7.5%
Max Revenue beat(2)-5.34%
Revenue beat(4)1
Avg Revenue beat(4)-2.89%
Min Revenue beat(4)-8.14%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-5.5%
Revenue beat(12)2
Avg Revenue beat(12)-6.46%
Revenue beat(16)4
Avg Revenue beat(16)-4.47%
PT rev (1m)8.74%
PT rev (3m)0.62%
EPS NQ rev (1m)-32.39%
EPS NQ rev (3m)-32.39%
EPS NY rev (1m)-12.22%
EPS NY rev (3m)9.39%
Revenue NQ rev (1m)-10.87%
Revenue NQ rev (3m)-10.87%
Revenue NY rev (1m)-2.1%
Revenue NY rev (3m)-2.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF N/A
P/OCF 81.7
P/B N/A
P/tB N/A
EV/EBITDA 53.5
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.14
OCFY1.22%
SpS9.65
BVpS-0.34
TBVpS-1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.85%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 16.32
Cap/Depr 27.84%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 38.66%
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.15
Altman-Z 0.14
F-Score6
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue 1Y (TTM)7.57%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A
EBIT growth 1Y65.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year230.63%
EBIT Next 3Y63.32%
EBIT Next 5YN/A
FCF growth 1Y96.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.03%
OCF growth 3YN/A
OCF growth 5YN/A